Lenore J Launer1, Timothy M Hughes, Lon R White. 1. Laboratory of Epidemiology, Demography, and Biometry, National Institute on Aging, Bethesda, MD 20892, USA. launerl@nia.nih.gov
Abstract
OBJECTIVE: This study was untaken to investigate the association of micro brain infarcts (MBIs) with antemortem global cognitive function (CF), and whether brain weight (BW) and Alzheimer lesions (neurofibrillary tangles [NFTs] or neuritic plaques [NPs]) mediate the association. METHODS: Subjects were 436 well-characterized male decedents from the Honolulu Asia Aging Autopsy Study. Brain pathology was ascertained with standardized methods, CF was measured by the Cognitive Abilities Screening Instrument, and data were analyzed using formal mediation analyses, adjusted for age at death, time between last CF measure and death, education, and head size. Based on antemortem diagnoses, demented and nondemented subjects were examined together and separately. RESULTS: In those with no dementia, MBIs were strongly associated with the last antemortem CF score; this was significantly mediated by BW, and not NFTs or NPs. In contrast, among those with an antemortem diagnosis of dementia, NFTs had the strongest associations with BW and with CF, and MBIs were modestly associated with CF. INTERPRETATION: This suggests that microinfarct pathology is a significant and independent factor contributing to brain atrophy and cognitive impairment, particularly before dementia is clinically evident. The role of vascular damage as initiator, stimulator, or additive contributor to neurodegeneration may differ depending on when in the trajectory toward dementia the lesions develop.
OBJECTIVE: This study was untaken to investigate the association of micro brain infarcts (MBIs) with antemortem global cognitive function (CF), and whether brain weight (BW) and Alzheimer lesions (neurofibrillary tangles [NFTs] or neuritic plaques [NPs]) mediate the association. METHODS: Subjects were 436 well-characterized male decedents from the Honolulu Asia Aging Autopsy Study. Brain pathology was ascertained with standardized methods, CF was measured by the Cognitive Abilities Screening Instrument, and data were analyzed using formal mediation analyses, adjusted for age at death, time between last CF measure and death, education, and head size. Based on antemortem diagnoses, demented and nondemented subjects were examined together and separately. RESULTS: In those with no dementia, MBIs were strongly associated with the last antemortem CF score; this was significantly mediated by BW, and not NFTs or NPs. In contrast, among those with an antemortem diagnosis of dementia, NFTs had the strongest associations with BW and with CF, and MBIs were modestly associated with CF. INTERPRETATION: This suggests that microinfarct pathology is a significant and independent factor contributing to brain atrophy and cognitive impairment, particularly before dementia is clinically evident. The role of vascular damage as initiator, stimulator, or additive contributor to neurodegeneration may differ depending on when in the trajectory toward dementia the lesions develop.
Authors: I J Martins; E Hone; J K Foster; S I Sünram-Lea; A Gnjec; S J Fuller; D Nolan; S E Gandy; R N Martins Journal: Mol Psychiatry Date: 2006-06-20 Impact factor: 15.992
Authors: Helen Petrovitch; G Webster Ross; Sandra C Steinhorn; Robert D Abbott; William Markesbery; Daron Davis; James Nelson; John Hardman; Kamal Masaki; Margaret R Vogt; Lenore Launer; Lon R White Journal: Ann Neurol Date: 2005-01 Impact factor: 10.422
Authors: L White; H Petrovitch; G W Ross; K H Masaki; R D Abbott; E L Teng; B L Rodriguez; P L Blanchette; R J Havlik; G Wergowske; D Chiu; D J Foley; C Murdaugh; J D Curb Journal: JAMA Date: 1996-09-25 Impact factor: 56.272
Authors: Susanne J van Veluw; Wilmar M T Jolink; Jeroen Hendrikse; Mirjam I Geerlings; Peter R Luijten; Geert Jan Biessels; Catharina J M Klijn Journal: J Cereb Blood Flow Metab Date: 2014-04-23 Impact factor: 6.200
Authors: David S Knopman; Michael E Griswold; Seth T Lirette; Rebecca F Gottesman; Kejal Kantarci; A Richey Sharrett; Clifford R Jack; Jonathan Graff-Radford; Andrea L C Schneider; B Gwen Windham; Laura H Coker; Marilyn S Albert; Thomas H Mosley Journal: Stroke Date: 2015-01-06 Impact factor: 7.914
Authors: Susanne J van Veluw; Jaco J M Zwanenburg; JooYeon Engelen-Lee; Wim G M Spliet; Jeroen Hendrikse; Peter R Luijten; Geert Jan Biessels Journal: J Cereb Blood Flow Metab Date: 2012-12-19 Impact factor: 6.200